New patent expiration for Boehringer Ingelheim drug TRADJENTA

Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There are ten patents…

The post New patent expiration for Boehringer Ingelheim drug TRADJENTA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.